NASDAQ:INBS Intelligent Bio Solutions Q2 2026 Earnings Results & Report $1.38 -0.11 (-7.09%) As of 11:20 AM Eastern This is a fair market value price provided by Massive. Learn more. Intelligent Bio Solutions missed analyst expectations on both earnings and revenue in its Q2 2026 results, released February 12, 2026. The company reported EPS of -$2.82 versus the $0.40 consensus estimate, while revenue of $0.90 million fell short of the $5.50 million estimate by $4.60 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateFebruary 12, 2026TimeBefore Market OpensConference Call7:00 AM ET Intelligent Bio Solutions EPS ResultsActual EPS-$2.82Consensus EPS $0.40Beat/MissMissed by -$3.22One Year Ago EPSN/AEPS Beat Rate1 of last 6 quartersIntelligent Bio Solutions Revenue ResultsActual Revenue$0.90 millionExpected Revenue$5.50 millionBeat/MissMissed by -$4.60 millionYoY Revenue GrowthN/AUpcoming EarningsIntelligent Bio Solutions' Q1 2027 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedules, with a conference call scheduled on Monday, November 9, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Intelligent Bio Solutions Q2 2026 Earnings FAQ Did Intelligent Bio Solutions beat earnings estimates for Q2 2026? Intelligent Bio Solutions (NASDAQ:INBS) reported earnings of -$2.82 per share for Q2 2026, missing the consensus estimate of $0.40. The report was announced on Thursday, February 12, 2026. What was Intelligent Bio Solutions' revenue for Q2 2026? Intelligent Bio Solutions reported revenue of $0.90 million for Q2 2026, against a consensus estimate of $5.50 million. When is Intelligent Bio Solutions' next earnings date? Intelligent Bio Solutions' next earnings date is estimated for Wednesday, November 11, 2026. MarketBeat tracks confirmed and estimated earnings dates for Intelligent Bio Solutions on the company's earnings history page. Intelligent Bio Solutions Earnings HeadlinesIntelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System TranscriptSeptember 24, 2026 | seekingalpha.comIntelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ETSeptember 10, 2026 | globenewswire.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.October 14 at 1:00 AM | Porter & Company (Ad)Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market ClearanceSeptember 9, 2026 | finanznachrichten.deIntelligent Bio Solutions Seeks FDA Clearance For Fingerprint-Based Drug Screening SystemSeptember 9, 2026 | rttnews.comIntelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market ClearanceSeptember 9, 2026 | globenewswire.comSee More Intelligent Bio Solutions Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Intelligent Bio Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intelligent Bio Solutions and other key companies, straight to your email. Email Address About Intelligent Bio SolutionsIntelligent Bio Solutions (NASDAQ:INBS) is a life sciences company developing rapid, non-invasive drug-screening technologies. Its primary product is the Intelligent Fingerprinting Drug Screening System, which analyzes sweat collected from a person’s fingerprint to identify the presence of commonly used drugs. The system combines a disposable drug-screening cartridge with a portable reader and associated software. By using fingerprint sweat rather than blood or urine, the company aims to provide a convenient testing option for organizations such as employers, law-enforcement agencies, drug-treatment providers and other healthcare or public-sector users. Intelligent Bio Solutions has roots in the development of diagnostic technologies and was formerly known as GBS Inc. The company markets its fingerprint-based screening products internationally, including in the United Kingdom and other markets, subject to applicable regulatory and commercial requirements. The company is led by Chief Executive Officer Harry Simeonidis.View Intelligent Bio Solutions ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American BusinessTax Credit Turmoil: Why Enphase and SolarEdge Face a Tough RoadSurgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?Venezuela's Oil Revival Is Gaining Momentum—3 Energy Stocks Positioned to Benefit Upcoming Earnings Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026)U.S. Bancorp (10/15/2026)Prologis (10/15/2026)Taiwan Semiconductor Manufacturing (10/15/2026)Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
